A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide or tirzepatide. Medscape Medical News
Category: News
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the indep…
MediPrint Ophthalmics Advances Glaucoma Program, Expands Patent Portfolio, and Prepares for Key Industry Presentation
SAN DIEGO–(BUSINESS WIRE)–MediPrint® Ophthalmics, a clinical-stage ophthalmic drug delivery company, continues to advance its innovative glaucoma program following the successful completion of its Phase 2b clinical trial for LL-BMT1. As the company p…
Bausch + Lomb Provides Update on Potential Sale
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, issued the following update on a potential sale, which was disclosed in December 2…
Warby Parker to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2024 will be releas…
Guanfacine for ADHD Increases Corneal Aberrations in Youth
Guanfacine used for treating ADHD in children and adolescents increases corneal aberrations at 6 months but does not affect the retina, choroid, refraction, or optic nerve. Medscape Medical News
iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems Inc. (“iVeena”), a biopharmaceutical company advancing IVMED-85 for the treatment of pediatric myopia, today announced that it has closed its fully subscribed Series B-2 financing of $3 million. …
Avian Influenza Landscape in the US
A recent study conducted on human A(H5N1) cases in the United States found that conjunctivitis was the primary symptom affecting individuals exposed to animals. Medscape Medical News
Strabismus Surgery Improves Vision in Older Adults
Surgical correction of strabismus improves measures of vision in patients over age 80 years, highlighting the safety and efficacy of the procedure in older adults, a study found. Medscape Medical News
When Doctors With AI Are Outperformed by AI Alone
Why we may need to rethink how we divide responsibilities between human physicians and AI systems to achieve the goal of synergy. Medscape
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment…
Sapio Sciences Selected by LabConnect to Transform Laboratory Operations
BALTIMORE–(BUSINESS WIRE)–Sapio Sciences, the science-aware™ lab informatics platform, today announced that LabConnect, a global leader in central laboratory services, has chosen Sapio LIMS (Laboratory Information Management System) to digitally tran…
McKesson Advances Specialty Leadership; Signs Agreement to Acquire Controlling Interest in PRISM Vision Holdings, LLC
IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC (PRISM Vision), a premier provider of general ophthalmology and retin…
Aldeyra Therapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
Inflammation Often Remains Following Tocilizumab Use for GCA
A recent study found that combined tocilizumab and glucocorticoid therapy for at least 6 months did not fully eliminate vascular inflammation in patients with giant cell arteritis. Medscape Medical News
Was a Novel Eye Treatment Approved Too Soon?
A published commentary raised several questions about a phase 3 trial that led to the FDA to approve a light therapy device for the treatment of age-related macular degeneration. Medscape Medical News
23andMe’s Business Woes Raise Privacy Concerns: Ethicist
Ethicist Art Caplan discusses data privacy concerns as troubled DNA testing company 23andMe faces a possible sale of its assets. Medscape Business of Medicine
Intraocular Lens Market Projected to Reach US$ 7.16 Billion by 2033 with Notable CAGR of 5.40%, Expansion Fueled by Aging Population and Technological Advancements – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intraocular Lens Market Report by Product, Material, End User, Region and Company Analysis 2025-2033” report has been added to ResearchAndMarkets.com’s offering. The global Intraocular Lens (IOL) market is poised for subst…
Adalimumab: To Stop or Not to Stop for JIA-Linked Uveitis?
Patients with JIA-associated uveitis who discontinued adalimumab had higher recurrence rates than those who continued the treatment, but they regained control upon restarting it. Medscape Medical News
Healthcare Resolutions for 2025
George Lundberg, MD, on how Americans can focus on the nation’s healthcare, not wealthcare. Medscape Internal Medicine